ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 120 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,534,000 | +103.6% | 38,010 | +30.3% | 0.00% | – |
| Q3 2021 | $1,736,000 | +20.2% | 29,174 | +37.8% | 0.00% | – |
| Q2 2021 | $1,444,000 | -21.5% | 21,169 | -20.1% | 0.00% | -100.0% |
| Q1 2021 | $1,839,000 | -2.1% | 26,502 | +8.4% | 0.00% | 0.0% |
| Q4 2020 | $1,878,000 | -14.9% | 24,451 | -17.1% | 0.00% | 0.0% |
| Q3 2020 | $2,208,000 | +240.7% | 29,507 | +186.4% | 0.00% | – |
| Q2 2020 | $648,000 | +66.6% | 10,304 | +11.3% | 0.00% | – |
| Q1 2020 | $389,000 | +80.1% | 9,257 | +94.8% | 0.00% | – |
| Q4 2019 | $216,000 | +83.1% | 4,753 | +84.0% | 0.00% | – |
| Q3 2019 | $118,000 | +24.2% | 2,583 | +59.4% | 0.00% | – |
| Q2 2019 | $95,000 | +46.2% | 1,620 | +12.0% | 0.00% | – |
| Q1 2019 | $65,000 | -8.5% | 1,447 | -21.0% | 0.00% | – |
| Q4 2018 | $71,000 | -53.6% | 1,832 | -45.1% | 0.00% | – |
| Q3 2018 | $153,000 | -78.6% | 3,337 | -79.6% | 0.00% | – |
| Q2 2018 | $714,000 | +462.2% | 16,383 | +409.3% | 0.00% | – |
| Q1 2018 | $127,000 | +4.1% | 3,217 | -10.9% | 0.00% | – |
| Q4 2017 | $122,000 | +5.2% | 3,610 | -20.6% | 0.00% | – |
| Q3 2017 | $116,000 | +2800.0% | 4,545 | +1965.9% | 0.00% | – |
| Q2 2017 | $4,000 | – | 220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |